| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |